Pfizer Inc. (PFE) Q1 2012 Earnings Results

Pfizer Beats on EPS, Stock Down 0.52%

Pfizer's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.52%. This could suggest investor concerns about future revenue growth or broader market conditions despite the EPS beat.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.58	N/A	+3.20%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Neutral

Management acknowledged the competitive landscape and its impact on performance. They reiterated their commitment to long-term growth through new product development.

Management highlighted ongoing challenges in the market.

They emphasized a focus on innovation and pipeline development.

Pfizer Beats on EPS, Stock Down 0.52%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 0.52%

Key numbers

Management commentary